Since Wegener's granulomatosis was first described in the nineteen thirties,5-7 numerous papers dealing with its clinical features, pathology, and treatment have appeared. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] It is characterised by a diagnostic triad consisting of granulomatous vasculitis of the upper and lower respiratory tract, a generalised small vessel vasculitis, and focal glomerulonephritis. 9 The sexes are affected equally, with a peak incidence in the fifth decade. Untreated patients die in about five months, usually of renal failure. [8] [9] [10] The initial lesions almost always occur in the respiratory tract.16 20 Upper respiratory tract manifestations start as a persistent "cold", with rhinorrhoea, epistaxis, and sinusitis.19 Later there is obstruction and ulceration of the nose and nasopharynx, perforation of the nasal septum, saddle nose deformity, and eventually horrific destruction of mid-facial structures.
In 95 % of patients the lungs are involved.1620 Radiological changes are impressive, but signs and symptoms are often minimal. Main complaints are of chest pain, cough, and haemoptysis. Pneumothorax, hydropneumothorax, and bronchopleural fistula have been described,2122 but clinical examination of the chest is usually unrewarding. Radiographs reveal a constantly changing pattern of opacities, predominantly in the lower lung fields. [21] [22] [23] [24] [25] [26] 47 The naked eye appearance of the lungs is essentially the same as Wegener's granulomatosis, but the lesions tend to be more coalescent and destructive. Vascular and bronchial obstruction lead to infarction and obstructive pneumonitis: the development of these secondary phenomena and their subsequent partial resolution accounts for the constantly changing radiological picture. Lesions are found in the kidneys in about one-third of cases and in the brain in about one-quarter.43 44 Glomerulonephritis does not occur. The adrenals, heart, pancreas, or prostate may also be affected, but lymph nodes are not involved unless a lymphoma develops. Massive hepatic infiltration has been described, but is unusual.43 44 48 Histologically 
Diagnosis
The most common diagnostic problem posed by this group of conditions is that of a patient with radiological opacities in the lungs. Clearly the differential diagnosis embraces almost any pulmonary disease, but there are a number of useful pointers. A history of asthma suggests Churg-Strauss syndrome or bronchocentric granulomatosis, and patients with classical Wegener's granulomatosis and ChurgStrauss syndrome62 often complain of upper respiratory tract symptoms. Physical examination is often unrewarding, but particular attention should be paid to the nose, nasopharynx and skin. The radiological lesions of Wegener's granulomatosis and lymphomatoid granulomatosis are often confined to the lower parts of the lung, and characteristically wax and wane.'323 43 In Wegener's granulomatosis there is usually anaemia, a high ESR, a positive rheumatoid factor, and derangement of immune globulins. Churg-Strauss syndrome and bronchocentric granulomatosis are associated with an eosinophilia.
In patients with upper respiratory tract manifestations the differential diagnosis includes all the conditions which cause the "lethal midline granuloma" syndrome.63 64 Again the history, clinical examination, and results of laboratory tests should suggest the nature of the underlying disorder.
The final diagnosis depends upon the correct interpretation of biopsy material. An adequate sample must be submitted to the pathologist. Biopsies of the bronchial mucosa, and transbronchial and needle biopsies of the lung parenchyma are too small and often unrepresentative: thoracotomy is essential.18 25 65 Biopsies of the upper respiratory tract should be as large as possible. The focal glomerulonephritis of classical Wegener's granulomatosis is of a non-specific type; renal biopsy has a place in management, but will not in itself confirm the diagnosis.
Treatment
It is now generally accepted that the treatment of choice in classical Wegener's granulomatosis is cyclophosphamide,20 66 67 which is curative in a large percentage of cases. It is often possible to taper off therapy when a complete remission has been obtained, although there may be problems with residual bronchial stenosis or interstitial lung disease.'8 27 Steroids have a place in the treatment of skin lesions, ocular manifestations and serosal involvement,18 and also in fulminating cases.20 68 Cyclophosphamide is advocated in the limited form of Wegener's granulomatosis by most authorities, but some suggest a period of observation when a solitary lesion has been excised. '7 There is no established treatment for lymphomatoid granulomatosis. A variety of combinations of steroids and chemotherapy have been used, but none has been found particularly effective.'7 44 Fauci and his colleagues20 have found cyclophosphamide effective in the early stages of the disease, whereas others advocate excision and radiotherapy44 or radiotherapy alone.69 70 The situation regarding the treatment of the other members of this group of diseases is problematical. Steroids54 and cyclophosphamide20 have both been used in the ChurgStrauss syndrome. Resection is curative in some cases of necrotising sarcoidal granulomatosis and bronchocentric granulomatosis, but steroids and chemotherapy still appear to have a place.59 61 Comment Classical Wegener's granulomatosis is a welldocumented clinico-pathological entity, and the site of the initial lesions, the immunoglobulin abnormalities, and the focal glomerulonephritis all suggest hypersensitivity to an inhaled antigen.'3 1617 34 The nature of the offending antigen remains obscure. No micro-organisms have been implicated, although secondary infection with Staphylococcus aureus and Pseudomonas aerogenosa is common.'6 18 The status of limited Wegener's granulomatosis is less certain at present. Many authorities feel that the two variants are part of the same disorder, and that the difference is only one of degree: the response to therapy is the same, and limited lesions may later become generalised.15 16 There is now some doubt concerning the position of lymphomatoid granulomatosis as a distinct entity. Malignant midline reticulosis, or polymorphic reticulosis, is one of the many disorders which cause the "lethal midline granuloma" syndrome.3 4 Histologically it is identical to lymphomatoid granulomatosis, and it has been suggested that the two conditions are essentially the same.3 75 76 The situation is further confused by reports of lymphomatoid granulomatosis affecting the upper respiratory tract and abdominal organs.73 [78] [79] [80] Churg-Strauss syndrome and polyarteritis nodosa are at the two ends of the systemic necrotising vasculitis spectrum.20 Polyarteritis 
